Spectaire (SPEC) Competitors $0.02 0.00 (-5.56%) (As of 12/20/2024 05:32 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends SPEC vs. TBIO, THMO, OLITW, PRENW, QSIAW, SMAPW, TT, KEYS, FTV, and VLTOShould you be buying Spectaire stock or one of its competitors? The main competitors of Spectaire include Telesis Bio (TBIO), ThermoGenesis (THMO), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), Trane Technologies (TT), Keysight Technologies (KEYS), Fortive (FTV), and Veralto (VLTO). These companies are all part of the "measuring and control equipment" industry. Spectaire vs. Telesis Bio ThermoGenesis OmniLit Acquisition Prenetics Global Quantum-Si SportsMap Tech Acquisition Trane Technologies Keysight Technologies Fortive Veralto Spectaire (NASDAQ:SPEC) and Telesis Bio (NASDAQ:TBIO) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, valuation, institutional ownership, dividends, earnings, profitability, media sentiment and risk. Does the MarketBeat Community prefer SPEC or TBIO? Telesis Bio received 9 more outperform votes than Spectaire when rated by MarketBeat users. Likewise, 52.94% of users gave Telesis Bio an outperform vote while only 0.00% of users gave Spectaire an outperform vote. CompanyUnderperformOutperformSpectaireOutperform VotesNo VotesUnderperform Votes1100.00% Telesis BioOutperform Votes952.94% Underperform Votes847.06% Which has more risk & volatility, SPEC or TBIO? Spectaire has a beta of -0.49, suggesting that its share price is 149% less volatile than the S&P 500. Comparatively, Telesis Bio has a beta of 1.58, suggesting that its share price is 58% more volatile than the S&P 500. Does the media refer more to SPEC or TBIO? In the previous week, Spectaire's average media sentiment score of 0.00 equaled Telesis Bio'saverage media sentiment score. Company Overall Sentiment Spectaire Neutral Telesis Bio Neutral Is SPEC or TBIO more profitable? Spectaire has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%. Spectaire's return on equity of -81.22% beat Telesis Bio's return on equity.Company Net Margins Return on Equity Return on Assets SpectaireN/A -81.22% 304.57% Telesis Bio -336.59%-359.32%-61.89% Do institutionals and insiders hold more shares of SPEC or TBIO? 26.5% of Spectaire shares are owned by institutional investors. Comparatively, 37.6% of Telesis Bio shares are owned by institutional investors. 25.4% of Spectaire shares are owned by company insiders. Comparatively, 24.5% of Telesis Bio shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has better valuation & earnings, SPEC or TBIO? Spectaire has higher earnings, but lower revenue than Telesis Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSpectaireN/AN/A$8.95MN/AN/ATelesis Bio$225.09M0.00-$47.72M-$28.20-0.02 SummarySpectaire and Telesis Bio tied by winning 5 of the 10 factors compared between the two stocks. Ad DTICackling Kamala hates this companyDo you want to see one of the most exciting election trades of all time? A trade that could help America become 100% energy independent… Reduce energy costs to virtually zero… And hand investors what could be a stunning return in just a few years’ time? It all has to do with a little known company that is helping to kick off the next great American energy revolution. Before that happens, you need to see the details here. Get Spectaire News Delivered to You Automatically Sign up to receive the latest news and ratings for SPEC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SPEC vs. The Competition Export to ExcelMetricSpectaireMeasuring & controlling devices IndustryComputer SectorNASDAQ ExchangeMarket Cap$313,000.00$18.87B$26.00B$9.08BDividend YieldN/A3.21%2.78%4.23%P/E RatioN/A19.16237.6917.18Price / SalesN/A9.493,345.53116.99Price / Cash0.0316.1035.7437.86Price / Book-0.013.048.134.78Net Income$8.95M$504.25M$681.78M$225.60M7 Day PerformanceN/A-4.12%0.41%-1.23%1 Month PerformanceN/A-3.98%7.02%3.36%1 Year PerformanceN/A-3.75%23.11%16.60% Spectaire Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SPECSpectaireN/A$0.02-5.6%N/A-99.0%$313,000.00N/A0.008Gap UpTBIOTelesis BioN/A$0.68+70.1%N/A-92.5%$1.21M$225.09M-0.01200Gap UpTHMOThermoGenesisN/A$0.00flatN/A-99.9%$4,000.00$9.61M0.0025OLITWOmniLit AcquisitionN/A$0.08+33.3%N/AN/A$0.00N/A0.003Gap UpHigh Trading VolumePRENWPrenetics GlobalN/A$0.01-17.2%N/A+2.0%$0.00$25.56M0.001Gap UpQSIAWQuantum-SiN/A$0.47+10.1%N/A+80.4%$0.00$2.27M0.00159Gap UpHigh Trading VolumeSMAPWSportsMap Tech AcquisitionN/A$0.02+1.6%N/AN/A$0.00N/A0.00N/ATTTrane Technologies4.1701 of 5 stars$398.68-0.2%$409.93+2.8%+58.1%$89.71B$19.39B37.0540,000Positive NewsKEYSKeysight Technologies4.8367 of 5 stars$171.00+2.7%$180.80+5.7%+4.2%$29.68B$4.98B49.0414,900Analyst RevisionFTVFortive4.7333 of 5 stars$76.76-0.1%$86.73+13.0%+4.0%$26.63B$6.20B30.5518,000Analyst ForecastVLTOVeralto2.259 of 5 stars$104.31+0.1%$109.50+5.0%+29.3%$25.80B$5.02B32.4016,000Dividend Increase Related Companies and Tools Related Companies TBIO Alternatives THMO Alternatives OLITW Alternatives PRENW Alternatives QSIAW Alternatives SMAPW Alternatives TT Alternatives KEYS Alternatives FTV Alternatives VLTO Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SPEC) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spectaire Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spectaire With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
